Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03531866 · ClinicalTrials.gov registry record · NA
Evaluation Study of Web-based Resource for Youth
A NA study, sponsored by Innovation Research & Training.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT03531866: Completed NA study, sponsored by Innovation Research & Training.
NCT03531866 is a NA study that has completed, run by Innovation Research & Training. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03531866, a NA study, has completed, sponsored by Innovation Research & Training.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
This study will evaluate DigiKnowIt News, a web-based resource to educate youth about pediatric clinical research. Youth will be randomly assigned to one of three groups (1. Intervention Version A; 2) Intervention Version B; 3) Wait-list control).
Primary Outcome
Questions will assess youth's factual knowledge about clinical research using a multiple choice format.
Interventions
- BEHAVIORAL DigiKnowIt News
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2018-05-24 |
| Est. Completion | 2018-08-17 |
| Phase | NA |
What the finished NCT03531866 record still lists
NCT03531866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which DigiKnowIt News is the first listed.
NCT03531866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03531866 about?
NCT03531866 is a clinical study titled "Evaluation Study of Web-based Resource for Youth". This study will evaluate DigiKnowIt News, a web-based resource to educate youth about pediatric clinical research. Youth will be randomly assigned to one of three groups (1. Intervention Version A; 2) Intervention Version B; 3) Wait-list control).
What is the current status of trial NCT03531866?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2018-05-24. Estimated completion is 2018-08-17.
What interventions are being tested in trial NCT03531866?
The interventions under investigation include: DigiKnowIt News (BEHAVIORAL).
Who is sponsoring clinical trial NCT03531866?
This trial is sponsored by Innovation Research & Training, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03531866's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI